Home » Topics » BioWorld Science, Neurology/psychiatric

BioWorld Science, Neurology/psychiatric
RSS

Arzneimittelwerk describes novel antiepileptic agents

April 11, 1997

Astra prepares NOS inhibitors

April 11, 1997

Selective 5-HT1Dalpha receptor agonists from MS&D

April 11, 1997

Pharmacia & Upjohn discontinues roquinimex MS trials

April 10, 1997

New carbamate derivative from Kyorin with high affinity/selectivity for M1 receptors

April 10, 1997

New bradykinin B2 antagonist from Fujisawa

April 10, 1997

Pharmacia & Upjohn describes compounds for amyloidosis

April 10, 1997

NMDA antagonist revealed by Sumitomo

April 10, 1997

Selfadministration device for Imitrex available in the U.S.

April 9, 1997

Agents for cerebral ischemia and neurodegenerative disorders from Boehringer Ingelheim

April 9, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 10, 2026.
Ionis, AZ shares down on unexpected Wainua flop in cardiomyopathy
BioWorld
News of the unexpected phase III failure of the gene silencing drug Wainua (eplontersen) in the treatment of transthyretin-mediated amyloid cardiomyopathy sent...
FENS 2026: Next-gen biologics take on brain disease
BioWorld
Whether by fine-tuning neurotransmitter signaling or silencing disease-associated genes, emerging biologic therapies are reshaping neuroscience drug development,...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
NRF2 activators reported in Vailima Peninsula patent
BioWorld Science
Vailima Peninsula Pty Ltd. has discovered new nuclear factor erythroid 2-related factor 2 (NFE2L2; NRF2) activators potentially useful for the treatment of...